Open AccessPrognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
Author(s) -
Jae Seung Lee,
Young Eun Chon,
Seung Up Kim,
Jun Yong Park,
Sang Hoon Ahn,
Kwang Hyub Han,
Wonseok Kang,
Moon Seok Choi,
Geum Youn Gwak,
Yong Han Paik,
Joon Hyeok Lee,
Kwang Cheol Koh,
Seung Woon Paik,
Hwi Young Kim,
Tae Hun Kim,
Kwon Yoo,
Yeonjung Ha,
Joo Ho Lee,
Seong Gyu Hwang,
Soon Sun Kim,
Hyo Jung Cho,
Jae Youn Cheong,
Sung Won Cho,
Seung Ha Park,
Nae–Yun Heo,
Young Mi Hong,
Ki Tae Yoon,
Mong Cho,
Jung Gil Park,
Min Kyu Kang,
Soo Young Park,
Young Oh Kweon,
Won Young Tak,
Se Young Jang,
Dong Hyun Sinn
Publication year - 2021
Publication title -
yonsei medical journal/yonsei medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.702
H-Index - 63
eISSN - 1976-2437
pISSN - 0513-5796
DOI - 10.3349/ymj.2021.62.1.12
Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , hazard ratio , alpha fetoprotein , overall survival , tumor progression , cancer , confidence interval
Alpha-fetoprotein (AFP) is a prognostic marker for hepatocellular carcinoma (HCC). We investigated the prognostic value of AFP levels in patients who achieved complete response (CR) to transarterial chemoembolization (TACE) for HCC.